<DOC>
	<DOCNO>NCT00142948</DOCNO>
	<brief_summary>Naltrexone medication currently use treat drug alcohol addiction . Guanfacine medication currently use manage withdrawal symptom individual undergo opioid detoxification . A combination two medication may beneficial reduce heroin use individual addict heroin . This study evaluate effectiveness naltrexone guanfacine , alone combination , reduce heroin use heroin addict .</brief_summary>
	<brief_title>Naltrexone Adrenergic Agents Reduce Heroin Use Heroin Addicts</brief_title>
	<detailed_description>Heroin addiction serious health problem available medical treatment prevent relapse . Naltrexone medication currently use treat substance addiction . It act block `` high '' feeling produce drug alcohol . Guanfacine , antihypertensive medication , currently use manage withdrawal symptom individual undergo opioid detoxification . While medication useful treatment heroin addiction , combination two drug may effective either medication alone . The purpose study compare effectiveness naltrexone , guanfacine , combination naltrexone guanfacine reduce drug relapse heroin addict . This study enroll individual addict heroin complete prior detoxification program one two addiction treatment hospital St. Petersburg , Russian Federation . Upon complete detoxification program 7-14 day , participant period inpatient rehabilitation . During 3- 4-week inpatient stabilization period , patient screen study participation . Once stabilize , participant begin 6-month treatment phase study . During phase , randomly assign receive one follow drug combination daily basis : 50 mg naltrexone guanfacine placebo ; 1.0 mg guanfacine naltrexone placebo ; 50 mg naltrexone 1.0 mg guanfacine ; naltrexone placebo guanfacine placebo . All participant designate family member responsible supervise medication compliance . Study visit occur twice monthly . Participants receive clinical management medication compliance counsel visit ; family member also take part counseling session . Outcome measurement include drug relapse , medication adherence , withdrawal symptom , HIV risk factor , psychiatric symptom . Follow-up evaluation occur 3 6 month follow end treatment .</detailed_description>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Adrenergic Agents</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Heroin</mesh_term>
	<criteria>Current primary diagnosis heroin dependence , least 1 year prior study entry High school graduate high education level Abstinence drug alcohol least 1 week prior study entry Negative urine breathalyzer test alcohol drug No evidence opioid dependence follow narcan challenge At least one relative willing participate treatment , monitor administration medication , assist followup , provide outcome data Stable address within St. Petersburg near district Leningrad Region Able provide home telephone number participant may reach If female , willing use effective contraception throughout study Low blood pressure , determine sit blood pressure le 90/50 mm Hg Clinically significant cognitive impairment , schizophrenia , paranoid disorder , bipolar disorder , seizure disorder Advanced brain , heart , kidney , liver disease Active tuberculosis Current febrile illness AIDSdefining illness Significant laboratory abnormality , include severe anemia , unstable diabetes , liver function test great three time normal Pending legal issue may entail jail stay study Currently participate another treatment study Currently participate another substance abuse program Current use psychotropic medication Pregnant Pulse rate le 50 bpm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Heroin Abuse</keyword>
	<keyword>Heroin Addiction</keyword>
</DOC>